Reference
DeMartino PC, et al. Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018. JAMA Internal Medicine : 9 Nov 2020. Available from: URL: http://doi.org/10.1001/jamainternmed.2020.5921
Rights and permissions
About this article
Cite this article
Cancer drugs approved by FDA in 2018 could greatly increase spending. PharmacoEcon Outcomes News 867, 4 (2020). https://doi.org/10.1007/s40274-020-7301-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7301-8